Bruns Ingmar
SEC CIK 1838041 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals, Inc. | Chief Medical Off | 33.3K | $45.6K | $7,998 | 3 | 2025-02-03 | 2026-02-06 |
Most active insiders at ZNTL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | WALTERS GROUP | 10% | $15.17M | — |
| 2 | GOEL DAVID E. | 10% | — | $9.97M |
| 3 | WALTERS WILLIAM THURMAN | 10% | $7.75M | — |
| 4 | Vultaggio Vincent | PAO, PFO | — | $105.4K |
| 5 | EASTLAND JULIA MARIE | CEO, Pres, Dir | — | $21.2K |
| 6 | Bruns Ingmar | Chief Medical Off | — | $7,998 |
| 7 | Campbell Shannon | Dir | — | — |
| 8 | Kariuki Enoch | Dir | — | — |
| 9 | Skvarka Jan | Dir | — | — |
| 10 | Johnson David Michael | Dir | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-02-10 | 2026-02-06+ | ZNTL | Zentalis Pharmaceuticals, Inc. | Bruns Ingmar | Chief Medical Off | S - Sale | $2.43 | -3,297 | 33.3K | -9% | -$7,998 |
| 2025-02-12 | 2025-02-06 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bruns Ingmar | Chief Medical Off | P - Purchase | $2.28 | +20.0K | 36.6K | +120% | +$45.6K | |
| D | 2025-02-05 | 2025-02-03 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bruns Ingmar | Chief Medical Off | A - Grant | $0.00 | +16.6K | 16.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations